| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5604396 | International Journal of Cardiology | 2017 | 6 Pages |
Abstract
Pre-PPCI point-of-care renal function testing did not reduce the incidence of CI-AKI in the overall group of STEMI patients. In patients with CKD, contrast dose was significantly reduced, but a numerical reduction in CI-AKI was not found to be statistically significant. No significant differences were found in the non-CKD group.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Grigoris V. Karamasis, James Hampton-Till, Firas Al-Janabi, Shah Mohdnazri, Michael Parker, Adam Ioannou, Rohan Jagathesan, Alagmir Kabir, Jeremy W. Sayer, Nicholas M. Robinson, Rajesh K. Aggarwal, Gerald J. Clesham, Reto A. Gamma, Paul A. Kelly,